CCCC Insider Trading

Insider Ownership Percentage: 7.97%
Insider Buying (Last 12 Months): $31,735.20
Insider Selling (Last 12 Months): $0.00

C4 Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at C4 Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

C4 Therapeutics Share Price & Price History

Current Price: $1.51
Price Change: Price Decrease of -0.06 (-3.82%)
As of 11/29/2023 01:00 AM ET

This chart shows the closing price history over time for CCCC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

C4 Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/8/2023Utpal KoppikarDirectorBuy5,667$5.60$31,735.205,667View SEC Filing Icon  
4/12/2022Andrew HirschCEOBuy10,000$8.40$84,000.0010,000View SEC Filing Icon  
12/17/2021Malcolm SalterDirectorSell755$30.25$22,838.75View SEC Filing Icon  
11/19/2021Malcolm SalterDirectorSell755$40.11$30,283.05View SEC Filing Icon  
10/15/2021Malcolm SalterDirectorSell755$44.94$33,929.70View SEC Filing Icon  
10/1/2021Adam CrystalInsiderSell15,000$45.43$681,450.00View SEC Filing Icon  
9/27/2021Elena ProkupetsDirectorSell1,850$50.04$92,574.00View SEC Filing Icon  
9/23/2021Elena ProkupetsDirectorSell19,180$50.41$966,863.80View SEC Filing Icon  
9/21/2021Elena ProkupetsDirectorSell10,321$50.14$517,494.94View SEC Filing Icon  
9/17/2021Elena ProkupetsDirectorSell10,840$50.05$542,542.00View SEC Filing Icon  
9/15/2021Elena ProkupetsDirectorSell54,193$48.82$2,645,702.26View SEC Filing Icon  
9/13/2021Elena ProkupetsDirectorSell6,660$50.07$333,466.20View SEC Filing Icon  
9/10/2021Elena ProkupetsDirectorSell2,550$50.00$127,500.00View SEC Filing Icon  
8/20/2021Malcolm SalterDirectorSell755$40.73$30,751.1513,672View SEC Filing Icon  
8/2/2021Elena ProkupetsDirectorSell4,257$45.01$191,607.57View SEC Filing Icon  
8/2/2021Stewart L. FisherInsiderSell18,104$45.00$814,680.00View SEC Filing Icon  
7/29/2021Elena ProkupetsDirectorSell11,336$45.00$510,120.00View SEC Filing Icon  
7/29/2021Jolie SiegelInsiderSell12,500$45.00$562,500.00View SEC Filing Icon  
7/16/2021Malcolm SalterDirectorSell755$37.37$28,214.3514,427View SEC Filing Icon  
7/1/2021Adam CrystalInsiderSell15,000$37.98$569,700.0015,000View SEC Filing Icon  
6/18/2021Malcolm SalterDirectorSell755$37.19$28,078.4514,843View SEC Filing Icon  
5/21/2021Malcolm SalterDirectorSell755$37.12$28,025.6015,598View SEC Filing Icon  
4/5/2021Adam CrystalInsiderSell15,000$37.77$566,550.0015,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for C4 Therapeutics (NASDAQ:CCCC)

74.88% of C4 Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CCCC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

C4 Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2023Jacobs Levy Equity Management Inc.864,481$1.61M0.0%+18.6%1.754%Search for SEC Filing on Google Icon
11/16/2023Tudor Investment Corp Et Al15,223$28K0.0%N/A0.031%Search for SEC Filing on Google Icon
11/16/2023Public Employees Retirement System of Ohio71,163$0.13M0.0%-65.7%0.144%Search for SEC Filing on Google Icon
11/15/2023AQR Capital Management LLC1,093,099$2.03M0.0%+98.0%2.218%Search for SEC Filing on Google Icon
11/14/2023Lynx1 Capital Management LP1,019,230$1.90M1.3%N/A2.068%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.164,722$0.31M0.0%-5.5%0.334%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC51,760$96K0.0%-12.4%0.105%Search for SEC Filing on Google Icon
11/13/2023Mariner LLC126,491$0.24M0.0%-10.8%0.257%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC28,014$51K0.0%-78.1%0.057%Search for SEC Filing on Google Icon
11/13/2023FMR LLC121,165$0.23M0.0%+121.2%0.246%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.57,894$0.11M0.0%+214.6%0.117%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG321,609$0.60M0.0%+19.2%0.653%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.248,252$0.46M0.0%+7.5%0.504%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC43,614$81K0.0%+30.7%0.089%Search for SEC Filing on Google Icon
11/2/2023M&T Bank Corp140,020$0.26M0.0%N/A0.285%Search for SEC Filing on Google Icon
10/24/2023Raymond James & Associates91,380$0.17M0.0%+8.5%0.186%Search for SEC Filing on Google Icon
10/20/2023Harbor Capital Advisors Inc.70,703$0.13M0.0%+20.6%0.144%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC33,368$92K0.0%-29.5%0.068%Search for SEC Filing on Google Icon
8/15/2023Public Employees Retirement System of Ohio207,456$0.57M0.0%+5.3%0.422%Search for SEC Filing on Google Icon
8/15/2023XTX Topco Ltd201,033$0.55M0.1%+494.1%0.409%Search for SEC Filing on Google Icon
8/15/2023Y Intercept Hong Kong Ltd75,900$0.21M0.0%+142.0%0.154%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.230,566$0.63M0.0%-33.3%0.469%Search for SEC Filing on Google Icon
8/15/2023DRW Securities LLC21,100$58K0.0%N/A0.043%Search for SEC Filing on Google Icon
8/15/2023Caxton Associates LP26,721$73K0.0%-31.4%0.054%Search for SEC Filing on Google Icon
8/15/2023Point72 Middle East FZE38,607$0.11M0.0%+297.9%0.078%Search for SEC Filing on Google Icon
8/14/2023PDT Partners LLC21,432$59K0.0%-72.7%0.044%Search for SEC Filing on Google Icon
8/14/2023State of Wyoming34,494$95K0.0%N/A0.070%Search for SEC Filing on Google Icon
8/14/2023Tower Research Capital LLC TRC 9,382$26K0.0%+144.6%0.019%Search for SEC Filing on Google Icon
8/14/2023ArrowMark Colorado Holdings LLC309,755$0.85M0.0%-95.1%0.630%Search for SEC Filing on Google Icon
8/14/2023State of Wisconsin Investment Board171,600$0.47M0.0%+22.2%0.349%Search for SEC Filing on Google Icon
8/14/2023TCG Crossover Management LLC1,276,574$3.51M0.6%+2.1%2.595%Search for SEC Filing on Google Icon
8/14/2023State Street Corp155,373$0.43M0.0%-79.9%0.316%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC34,000$94K0.0%N/A0.069%Search for SEC Filing on Google Icon
8/14/2023Graham Capital Management L.P.32,974$91K0.0%N/A0.067%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC516,898$1.42M0.0%+58.5%1.051%Search for SEC Filing on Google Icon
8/11/2023Pale Fire Capital SE19,200$53K0.0%N/A0.039%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.2,086,563$5.74M0.0%-43.6%4.242%Search for SEC Filing on Google Icon
8/11/2023B. Metzler seel. Sohn & Co. AG66,276$0.18M0.0%+265.8%0.135%Search for SEC Filing on Google Icon
8/11/2023The Manufacturers Life Insurance Company 65,195$0.18M0.0%-20.3%0.133%Search for SEC Filing on Google Icon
8/11/2023Hsbc Holdings PLC32,653$90K0.0%+74.1%0.066%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC438,959$1.21M0.0%-47.8%0.892%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp91,158$0.25M0.0%-76.3%0.185%Search for SEC Filing on Google Icon
8/10/2023Russell Investments Group Ltd.78,133$0.22M0.0%+32.4%0.159%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.231,034$0.64M0.0%-27.1%0.471%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.18,402$51K0.0%+1,196.8%0.038%Search for SEC Filing on Google Icon
8/9/2023Dimensional Fund Advisors LP263,384$0.72M0.0%-31.1%0.537%Search for SEC Filing on Google Icon
8/8/2023Wasatch Advisors LP7,199,491$19.80M0.1%+26.0%14.675%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC128,060$0.35M0.0%N/A0.261%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC33,368$92K0.0%-29.5%0.068%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp22,281$61K0.0%-85.3%0.045%Search for SEC Filing on Google Icon
7/25/2023Raymond James & Associates84,234$0.23M0.0%+33.5%0.172%Search for SEC Filing on Google Icon
7/11/2023Harbor Capital Advisors Inc.58,647$0.16M0.0%+10.1%0.120%Search for SEC Filing on Google Icon
7/10/2023SG Americas Securities LLC12,810$35K0.0%-54.3%0.026%Search for SEC Filing on Google Icon
5/22/2023Ameriprise Financial Inc.80,135$0.25M0.0%+107.3%0.163%Search for SEC Filing on Google Icon
5/18/2023JPMorgan Chase & Co.33,863$0.11M0.0%-66.3%0.069%Search for SEC Filing on Google Icon
5/18/2023New York State Common Retirement Fund7,864$25K0.0%-72.5%0.016%Search for SEC Filing on Google Icon
5/16/2023Susquehanna Fundamental Investments LLC17,572$55K0.0%-45.9%0.036%Search for SEC Filing on Google Icon
5/16/2023Susquehanna International Group LLP268,067$0.84M0.0%+675.6%0.546%Search for SEC Filing on Google Icon
5/16/2023Jane Street Group LLC100,741$0.32M0.0%N/A0.205%Search for SEC Filing on Google Icon
5/16/2023State Street Corp774,221$2.43M0.0%-68.4%1.578%Search for SEC Filing on Google Icon
5/16/2023Squarepoint Ops LLC107,632$0.34M0.0%+96.7%0.219%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC840,778$2.64M0.0%+5.5%1.714%Search for SEC Filing on Google Icon
5/16/2023AQR Capital Management LLC606,465$1.90M0.0%+120.5%1.236%Search for SEC Filing on Google Icon
5/16/2023ArrowMark Colorado Holdings LLC6,380,880$20.04M0.2%+10.0%13.005%Search for SEC Filing on Google Icon
5/15/2023Cubist Systematic Strategies LLC14,560$46K0.0%-67.7%0.030%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP400,300$1.26M0.0%+53.1%0.816%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP263,264$0.83M0.0%+122.6%0.537%Search for SEC Filing on Google Icon
5/15/2023Deutsche Bank AG25,932$81K0.0%+45.9%0.053%Search for SEC Filing on Google Icon
5/15/2023Price T Rowe Associates Inc. MD2,875,374$9.03M0.0%-1.7%5.860%Search for SEC Filing on Google Icon
5/15/2023XTX Topco Ltd33,839$0.11M0.0%+139.1%0.069%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC326,080$1.02M0.0%+903.3%0.665%Search for SEC Filing on Google Icon
5/12/2023Cresset Asset Management LLC11,281$35K0.0%-75.4%0.023%Search for SEC Filing on Google Icon
5/12/2023Wasatch Advisors LP5,716,021$17.95M0.1%-1.0%11.650%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.3,696,742$11.61M0.0%+2.1%7.535%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE51,488$0.16M0.0%-73.6%0.105%Search for SEC Filing on Google Icon
5/12/2023HRT Financial LP119,612$0.38M0.0%N/A0.244%Search for SEC Filing on Google Icon
5/12/2023UBS Group AG162,650$0.51M0.0%-39.8%0.332%Search for SEC Filing on Google Icon
5/12/2023Martingale Asset Management L P39,420$0.12M0.0%+20.6%0.080%Search for SEC Filing on Google Icon
5/12/2023Wellington Management Group LLP124,810$0.39M0.0%-7.4%0.254%Search for SEC Filing on Google Icon
5/12/2023Panagora Asset Management Inc.107,891$0.34M0.0%N/A0.220%Search for SEC Filing on Google Icon
5/12/2023Charles Schwab Investment Management Inc.317,009$1M0.0%-11.1%0.646%Search for SEC Filing on Google Icon
5/11/2023M&T Bank Corp72,000$0.23M0.0%+17.5%0.147%Search for SEC Filing on Google Icon
5/11/2023Cornercap Investment Counsel Inc.48,047$0.15M0.0%+82.8%0.098%Search for SEC Filing on Google Icon
5/11/2023ExodusPoint Capital Management LP10,551$33K0.0%N/A0.022%Search for SEC Filing on Google Icon
5/10/2023B. Metzler seel. Sohn & Co. AG18,120$57K0.0%N/A0.037%Search for SEC Filing on Google Icon
5/10/2023Swiss National Bank73,900$0.23M0.0%-10.5%0.151%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.113,893$0.36M0.0%+687.8%0.232%Search for SEC Filing on Google Icon
5/9/2023Y Intercept Hong Kong Ltd31,362$98K0.0%N/A0.064%Search for SEC Filing on Google Icon
5/9/2023Russell Investments Group Ltd.59,034$0.19M0.0%+30.5%0.120%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC47,363$0.15M0.0%-54.3%0.097%Search for SEC Filing on Google Icon
4/28/2023SG Americas Securities LLC28,013$88K0.0%-32.6%0.057%Search for SEC Filing on Google Icon
4/26/2023Harbor Capital Advisors Inc.53,278$0.17M0.0%+113.7%0.109%Search for SEC Filing on Google Icon
2/16/2023Alliancebernstein L.P.52,000$0.31M0.0%+9.0%0.106%Search for SEC Filing on Google Icon
2/15/2023Public Employees Retirement System of Ohio197,045$1.16M0.0%-15.1%0.402%Search for SEC Filing on Google Icon
2/15/2023CI Private Wealth LLC11,380$67K0.0%N/A0.023%Search for SEC Filing on Google Icon
2/15/2023State of Wisconsin Investment Board134,674$0.80M0.0%+20.7%0.275%Search for SEC Filing on Google Icon
2/15/2023Susquehanna Fundamental Investments LLC32,496$0.19M0.0%N/A0.066%Search for SEC Filing on Google Icon
2/15/2023Soleus Capital Management L.P.2,440,843$14.40M2.1%+69.3%4.985%Search for SEC Filing on Google Icon
2/15/2023Squarepoint Ops LLC54,721$0.32M0.0%+157.5%0.112%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley379,199$2.24M0.0%+10.1%0.775%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
C4 Therapeutics logo
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies; CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC; and earlier stage programs comprising RET degraders for the treatment of various cancers. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Read More on C4 Therapeutics

Today's Range

Now: $1.51
Low: $1.51
High: $1.69

50 Day Range

MA: $1.70
Low: $1.32
High: $2.19

52 Week Range

Now: $1.51
Low: $1.23
High: $9.41

Volume

181,905 shs

Average Volume

701,620 shs

Market Capitalization

$74.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.23

Who are the company insiders with the largest holdings of C4 Therapeutics?

C4 Therapeutics' top insider shareholders include:
  1. Andrew Hirsch (CEO)
  2. Utpal Koppikar (Director)
  3. Malcolm Salter (Director)
Learn More about top insider investors at C4 Therapeutics.

Who are the major institutional investors of C4 Therapeutics?

C4 Therapeutics' top institutional investors include:
  1. AQR Capital Management LLC — 2.22%
  2. Lynx1 Capital Management LP — 2.07%
  3. Jacobs Levy Equity Management Inc. — 1.75%
  4. UBS Group AG — 0.65%
  5. Charles Schwab Investment Management Inc. — 0.50%
  6. Connor Clark & Lunn Investment Management Ltd. — 0.33%
Learn More about top institutional investors of C4 Therapeutics stock.

Which major investors are selling C4 Therapeutics stock?

In the last quarter, CCCC stock was sold by these institutional investors:
  1. Public Employees Retirement System of Ohio
  2. Acadian Asset Management LLC
  3. Mariner LLC
  4. Connor Clark & Lunn Investment Management Ltd.
  5. Algert Global LLC

Which major investors are buying C4 Therapeutics stock?

In the previous quarter, CCCC stock was bought by institutional investors including:
  1. Lynx1 Capital Management LP
  2. AQR Capital Management LLC
  3. M&T Bank Corp
  4. Jacobs Levy Equity Management Inc.
  5. FMR LLC
  6. UBS Group AG
  7. Citigroup Inc.
  8. Charles Schwab Investment Management Inc.
During the last year, these company insiders have bought C4 Therapeutics stock:
  1. Andrew Hirsch (CEO)
  2. Utpal Koppikar (Director)
Learn More investors buying C4 Therapeutics stock.